₹-1.25
(Market cap
₹2,833 Cr
Recently Viewed
Clear AllMarket cap
₹2,833 Cr
Revenue (TTM)
₹2,291 Cr
P/E Ratio
20.6
P/B Ratio
2.2
Div. Yield
0.1 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹138 Cr
ROE
12.2 %
ROCE
16.1 %
Industry P/E
36.29
EV/EBITDA
11
Debt to Equity
0.2
Book Value
₹231.8
EPS
₹24.9
Face value
2
Shares outstanding
55,383,366
CFO
₹563.07 Cr
EBITDA
₹1,275.00 Cr
Net Profit
₹711.13 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rossari Biotech
| -12.2 | 24.3 | -3.7 | -25.9 | -9.4 | -14.2 | -- |
|
BSE Commodities
| 5.8 | 10.8 | 4.8 | 14.9 | 18.3 | 13.5 | 16.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Rossari Biotech
| -26.6 | -2.8 | 9.9 | -43.3 | 37.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rossari Biotech
|
511.4 | 2,832.6 | 2,291.1 | 136.2 | 8.9 | 11.3 | 20.6 | 2.2 |
| 465.9 | 16,891.5 | 8,045.0 | 378.0 | 7.8 | 6.6 | 44.7 | 2.9 | |
| 1,181.4 | 15,714.6 | 1,088.6 | 215.8 | 27.4 | 9.8 | 72.8 | 6.6 | |
| 1,341.0 | 15,269.3 | 2,229.8 | 229.1 | 18.1 | 5.7 | 88.8 | 4.7 | |
| 1,731.9 | 23,611.0 | 7,946.4 | 533.3 | 8.9 | 9.9 | 44.3 | 4.2 | |
| 4,978.7 | 15,261.5 | 2,347.3 | 398.8 | 17.9 | 16.4 | 38.5 | 6.0 | |
| 4,195.7 | 9,750.3 | 2,071.4 | 307.8 | 17.4 | 12.6 | 31.7 | 3.8 | |
| 735.8 | 11,715.1 | 4,260.9 | 265.7 | 9.0 | 9.2 | 44.1 | 3.8 | |
| 3,250.8 | 12,696.8 | 2,455.7 | 286.6 | 18.6 | 25.6 | 42.3 | 9.7 | |
| 1,299.2 | 13,472.9 | 2,271.4 | 442.9 | 24.7 | 15.5 | 30.4 | 4.4 |
No Review & Analysis are available.
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment... solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it offers poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 1997 and is based in Mumbai, India. Read more
Incorporated
2003
Chairman
Edward Menezes
Managing Director
Sunil Chari
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Rossari Biotech Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Rossari Biotech Ltd is ₹511.35 (NSE) and ₹511.45 (BSE) as of 23-Apr-2026 IST. Rossari Biotech Ltd has given a return of -9.35% in the last 3 years.
The P/E ratio of Rossari Biotech Ltd is 20.57 times as on 23-Apr-2026, a 43 discount to its peers’ median range of 36.29 times.
The P/B ratio of Rossari Biotech Ltd is 2.21 times as on 23-Apr-2026, a 0 premium to its peers’ median range of 2.20 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
24.52
|
2.83
|
|
2024
|
28.51
|
3.57
|
|
2023
|
30.61
|
3.60
|
|
2022
|
51.49
|
6.27
|
|
2021
|
67.17
|
13.25
|
The 52-week high and low of Rossari Biotech Ltd are Rs 766.00 and Rs 375.00 as of 23-Apr-2026.
Rossari Biotech Ltd has a market capitalisation of ₹ 2,833 Cr as on 23-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Rossari Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.